【Tokyo, Chofu City】'Metallo Balance Test' for Cancer and Cognitive (MCI: Mild Cognitive Impairment) Risk Assessment with Just 6mL Blood Draw Now Accepting Reservations from August at Somiji 3-chome Clinic

Renatech Inc. (Headquarters: Isehara City, Kanagawa Prefecture), a company that develops health indicators based on trace elements and applies them to real-world use, announces the opening of reservations for its self-developed screening test 'Metallo Balance Test,' which evaluates the risk of cancer and MCI (Mild Cognitive Impairment), at its partner medical institution 'Somiji 3-chome Clinic' (Chofu City, Tokyo) for the period from August to October 2026.

With the establishment of a continuous testing system at this clinic, access to the 'Metallo Balance Test' in the Chofu City area will be stably secured, contributing as a convenient option for local residents' daily health management and pre-disease prevention.

The company will continue to work with partner medical institutions nationwide to maintain and expand testing availability, aiming to encourage more people to take interest in their health and reflect on their daily habits and lifestyle as part of pre-disease prevention.

What is the Metallo Balance (MB) Test?

The Metallo Balance Test is a risk screening (triage) test that objectively assesses the risk of cancer and MCI (Mild Cognitive Impairment) at the time of blood draw by analyzing the concentration balance of 17 trace elements (metal elements) in the blood.

【Features of the Test】

Only one 6mL blood draw: Blood is safely collected under proper medical supervision. The test takes approximately 15 minutes, minimizing physical burden and ensuring safety.

Site-specific 'Cancer Risk Test': With a single blood draw, cancer risk is evaluated by site (6 sites for men, 9 for women) and scored on a four-tier scale from A to D. [Men] Lung cancer, stomach cancer, liver cancer, pancreatic cancer, colorectal cancer, prostate cancer [Women] Lung cancer, stomach cancer, liver cancer, pancreatic cancer, colorectal cancer, breast cancer, cervical cancer, endometrial cancer, ovarian cancer

Comprehensive 'Cognitive Risk Test (MCI Risk Assessment)': Evaluates all types of MCI, including Alzheimer's, vascular, and Lewy body types.

Proven research results and international recognition: Developed through joint research with Kanagawa Prefectural Cancer Center and Chiba Cancer Center, supported by a research grant from the Ministry of Economy, Trade and Industry's Go-Tech program. Patented in 9 countries including Japan, with over 100,000 test takers cumulatively (from April 2019 to March 2026).

Testing Process and Key Pre-Test Instructions

※ Due to the need for document mailing procedures, advance registration is required approximately 3 weeks before the desired test date (by complete reservation system).

Registration: Please register via the website or by phone. A complete set of test documents will be delivered to your home about one week before your appointment.

Test Day (Blood Draw): As the system is fully reserved, blood draw proceeds smoothly (takes about 15 minutes). Payment is made after the test, so no on-site payment is required.

Results Notification: Approximately 3 weeks after blood draw, an invoice (payment slip) will be mailed to your home, followed by the test results approximately 5 weeks later.

【Key Pre-Test Instructions】

Food and Alcohol: No food after 9 PM the previous day. No alcohol from the previous day. Hydration: Drink plenty of water to facilitate blood draw.

Medications and Supplements: Over-the-counter medications and supplements must be discontinued from the previous day. Prescription medications should be taken as usual.

Test Fees (Private Pay)

This test is not covered by health insurance and is offered as a private-pay service. Choose from the following plans based on your needs.

Cancer Risk Test: ¥19,800 (tax included)

Cognitive Risk Test: ¥19,800 (tax included)

Cancer and Cognitive Risk Test Set: ¥24,200 (tax included)

※ Listed prices are standard prices. ※ Payment will be made via 'DSK Postpay,' delivered to your home after blood draw. ※ Some medical institutions may not offer one of the tests.

Eligibility and Important Notes for the Metallo Balance Test

【Age Eligibility】

Cancer Risk Test: Japanese nationals aged 20 to 80

Cognitive Risk Test: Japanese nationals aged 50 to 80

※ This test was developed based on data from Japanese individuals within the above age ranges. While individuals outside this age range or non-Japanese nationals may still take the test, results will be for reference only. Please understand in advance.

【Individuals Who Cannot Take the Test】

Pregnant individuals or those within 6 months postpartum

Individuals currently undergoing cancer treatment or within 1 year of completing treatment

Individuals undergoing dialysis

Individuals with fractures, blood disorders, or immunodeficiency (excluding lipid disorders such as high triglycerides)

Individuals in poor health (e.g., lack of sleep, after an all-nighter, immediately after intense exercise, under severe stress, or experiencing symptoms such as cold, asthma, shingles, allergic rash, or rhinitis)

Overview of Partner Medical Institution

Test Schedule: Generally every Monday, Friday, and Saturday (excluding holidays and clinic closure days)

Medical Institution Name: Somiji 3-chome Clinic

Address: 3-1-435 Somiji, Chofu City, Tokyo 182-0023 🅿️ Parking available 📍MAP

Access: Bus stop: Chofu Third Junior High School—right after getting off

Available Tests: Cancer Risk Test and Cognitive Risk Test

▼ Check Available Dates and Make a Reservation

The testing schedule for August to October, as well as the latest schedule from November onward, can be viewed and booked at any time via the following web reservation system.

Metallo Balance Test Web Reservation: https://metallo-balance.net/entry/

＜Steps to Check Dates and Apply＞

Select 'General Public' (red button) on the URL above

Select the relevant region (Kanto > Tokyo) under 'Find Test Site'

Select 'Somiji 3-chome Clinic' as the test site to view currently available specific test dates. ※ Each testing slot has a capacity limit. Registration will close once full, so please understand in advance.

⚠️ Important Request Regarding Testing (Please Read Carefully) Please refrain from contacting the medical institution directly: The hospital front desk or phone line cannot handle inquiries or reservations for this test. Please contact Renatech directly for any questions or reservations.

For details and reservations, please visit:

Metallo Balance Test Information Site (for full details): https://www.mbkensa.com/

Toll-Free Number: 0120-785-602 (Renatech: Weekdays 9:00–17:00)

▼ Digital Version of Metallo Balance Test Brochure

d182526-40-ddf81ebbd11e73e815cb8cdb8d5f0661.pdf

🏥 Partner medical institutions nationwide are also being recruited! For information on introducing the Metallo Balance Test, click here.

Metallo-Balance Original Character: Metalona-chan

Renatech Inc. is an innovation company developing proprietary technologies in the medical and health fields, as well as environmental fields, aiming for early risk assessment of diseases such as cancer. It has been selected as one of the '300 Outstanding SMEs and Small Businesses' by the Ministry of Economy, Trade and Industry and the Small and Medium Enterprise Agency, recognizing its high technological capability and social contribution.

Among these, the 'Metallo Balance Test' analyzes the concentration of 17 trace elements in the blood